Toronto Cardiac Tumour Conference

 

Toronto Cardiac Tumour Conference
V

Neoadjuvant Chemotherapy: Evidence, Rationale and Approach. Is Combination Chemotherapy preferred over Single Agent Chemo? Is a Combination of Adriamycin and Ifosfamide the Preffered First Line Agent?

By Toronto Cardiac Tumour Conference FEATURING Vinod Ravi
By Toronto Cardiac Tumour Conference FEATURING Vinod Ravi
0 views
September 3, 2020
Comments 0
Login to view comments. Click here to Login
2020
38:29
Toronto Cardiac Tumour Conference

Discussion: Undifferentiated Spindle Cell Neoplasm Treatment Options…

Feat. A. Abdul, A. Mashari, B. Van Tine, K. Jawad, R. Cusimano, A. Gupta, M. Farkouh, D. Schultz
04:12
Toronto Cardiac Tumour Conference

Case Presentation: Undifferentiated Spindle Cell Neoplasm Treated wi…

Feat. K. Jawad
05:20
Toronto Cardiac Tumour Conference

Case Presentation: Angiosarcoma Grade 3/3 with Mediastinal Lymphaden…

Feat. G. Watson
13:36
Toronto Cardiac Tumour Conference

Canadian Sarcoma Database (CanSARCC): Is There a Value in Creating a…

Feat. A. Gupta
34:39
Toronto Cardiac Tumour Conference

Discussion: Angiosarcoma Grade 3/3 with Mediastinal Lymphadenopathy …

Feat. A. Abdul, D. Schultz, A. Mashari, B. Van Tine, G. Watson, A. Gupta, R. Cusimano, M. Farkouh
17:41
Toronto Cardiac Tumour Conference

Panel Discussion: Canadian Sarcoma Database (CanSARCC): How Can It B…

Feat. A. Gupta
23:27
Toronto Cardiac Tumour Conference

Panel Discussion: The Importance of Starting a Cardiac Tumor Registr…

Feat. M. Farkouh, D. Schultz
46:19
Toronto Cardiac Tumour Conference

Is There a Difference in Efficacy Between Doxorubicin Bolus and Infu…

Feat. A. Mashari, R. Cusimano, K. Jawad, G. Watson, R. Jones
26:59
Toronto Cardiac Tumour Conference

Neoadjuvant Chemotherapy: Evidence, Rationale and Approach. Is Combi…

Feat. V. Ravi
31:22
Toronto Cardiac Tumour Conference

Beyond Chemotherapy in Cardiac Sarcomas: What Histological Subtypes …

Feat. R. Jones
13:50
Toronto Cardiac Tumour Conference

Adjuvant Therapies for Cardiac Malignancies: How Rare Are Cardiac Tu…

Feat. R. Cusimano
17:48
Toronto Cardiac Tumour Conference

The Role of Radiotherapy in the Management of Cardiac Tumours: Which…

Feat. D. Schultz
37:45
Toronto Cardiac Tumour Conference

Sarcoma Metabolism: What Metabolic Biomarkers Do We Have and What Th…

Feat. B. Van Tine
28:37
Toronto Cardiac Tumour Conference

Patient-specific 3D Modeling of Cardiac Tumors: What Are the Basic C…

Feat. A. Mashari
16:47
Toronto Cardiac Tumour Conference

Adjuvant Therapies in Cardiac Sarcomas: What Shold Be the Standard o…

Feat. A. Abdul